Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction

Background:. Biomaterials derived from human adipose extracellular matrix have shown promise in vitro and in animal studies as an off-the-shelf adipogenic matrix for sustained volume replacement. Herein, we report the results of a randomized prospective study conducted with allograft adipose matrix...

Full description

Bibliographic Details
Main Authors: Lauren E. Kokai, PhD, Wesley N. Sivak, MD, PhD, Benjamin K. Schilling, MS, Arivarasan Karunamurthy, MD, Francesco M. Egro, MBChB, MSc, MRCS, M. Asher Schusterman, MD, Danielle M. Minteer, PhD, Patsy Simon, RN, BS, Richard A. D’Amico, MD, J. Peter Rubin, MD
Format: Article
Language:English
Published: Wolters Kluwer 2020-01-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000002574
id doaj-d26f7ef31ebe483e9207c52bf486c8a9
record_format Article
spelling doaj-d26f7ef31ebe483e9207c52bf486c8a92020-11-25T03:07:14ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742020-01-0181e257410.1097/GOX.0000000000002574202001000-00014Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue ReconstructionLauren E. Kokai, PhD0Wesley N. Sivak, MD, PhD1Benjamin K. Schilling, MS2Arivarasan Karunamurthy, MD3Francesco M. Egro, MBChB, MSc, MRCS4M. Asher Schusterman, MD5Danielle M. Minteer, PhD6Patsy Simon, RN, BS7Richard A. D’Amico, MD8J. Peter Rubin, MD9From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.§ Division of Molecular & Genomic Pathology, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.¶ Department of Plastic Surgery, Mount Sinai School of Medicine, New York, N.Y.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.Background:. Biomaterials derived from human adipose extracellular matrix have shown promise in vitro and in animal studies as an off-the-shelf adipogenic matrix for sustained volume replacement. Herein, we report the results of a randomized prospective study conducted with allograft adipose matrix (AAM) grafted into the pannus of presurgical abdominoplasty patients 3 or 6 months before scheduled surgery. This is the first report of a longitudinal histologic analysis of AAM in clinical use. Methods:. Ten healthy patients undergoing elective abdominoplasty were recruited to receive AAM before surgery. Enrolled subjects were randomized into either a 3-month follow-up cohort or a 6-month follow-up cohort. Subjects were monitored for adverse events associated with AAM grafting in addition to undergoing serial biopsy. Following surgical excision of the pannus, representative samples from the AAM surgical sites were stained and evaluated with hematoxylin and eosin for tissue morphology, Masson’s trichrome for collagen, and perilipin for adipocytes. Results:. All subjects tolerated AAM with no severe adverse events reported. At 3 months following implantation, AAM remained visible within the confines of the subjects’ native surrounding adipose tissue with sparse adipocytes apparent within the matrix. By 6 months, AAM had remodeled and was primarily composed of perilipin-positive adipocytes. Histologic analysis confirmed tissue remodeling (hematoxylin and eosin), adipogenesis (perilipin), and angiogenesis (Masson’s trichrome) occurred with the presence of AAM. Conclusions:. AAM is a safe, allogeneic, off-the-shelf regenerative matrix that is adipogenic and noninflammatory and promotes angiogenesis.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000002574
collection DOAJ
language English
format Article
sources DOAJ
author Lauren E. Kokai, PhD
Wesley N. Sivak, MD, PhD
Benjamin K. Schilling, MS
Arivarasan Karunamurthy, MD
Francesco M. Egro, MBChB, MSc, MRCS
M. Asher Schusterman, MD
Danielle M. Minteer, PhD
Patsy Simon, RN, BS
Richard A. D’Amico, MD
J. Peter Rubin, MD
spellingShingle Lauren E. Kokai, PhD
Wesley N. Sivak, MD, PhD
Benjamin K. Schilling, MS
Arivarasan Karunamurthy, MD
Francesco M. Egro, MBChB, MSc, MRCS
M. Asher Schusterman, MD
Danielle M. Minteer, PhD
Patsy Simon, RN, BS
Richard A. D’Amico, MD
J. Peter Rubin, MD
Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction
Plastic and Reconstructive Surgery, Global Open
author_facet Lauren E. Kokai, PhD
Wesley N. Sivak, MD, PhD
Benjamin K. Schilling, MS
Arivarasan Karunamurthy, MD
Francesco M. Egro, MBChB, MSc, MRCS
M. Asher Schusterman, MD
Danielle M. Minteer, PhD
Patsy Simon, RN, BS
Richard A. D’Amico, MD
J. Peter Rubin, MD
author_sort Lauren E. Kokai, PhD
title Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction
title_short Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction
title_full Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction
title_fullStr Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction
title_full_unstemmed Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction
title_sort clinical evaluation of an off-the-shelf allogeneic adipose matrix for soft tissue reconstruction
publisher Wolters Kluwer
series Plastic and Reconstructive Surgery, Global Open
issn 2169-7574
publishDate 2020-01-01
description Background:. Biomaterials derived from human adipose extracellular matrix have shown promise in vitro and in animal studies as an off-the-shelf adipogenic matrix for sustained volume replacement. Herein, we report the results of a randomized prospective study conducted with allograft adipose matrix (AAM) grafted into the pannus of presurgical abdominoplasty patients 3 or 6 months before scheduled surgery. This is the first report of a longitudinal histologic analysis of AAM in clinical use. Methods:. Ten healthy patients undergoing elective abdominoplasty were recruited to receive AAM before surgery. Enrolled subjects were randomized into either a 3-month follow-up cohort or a 6-month follow-up cohort. Subjects were monitored for adverse events associated with AAM grafting in addition to undergoing serial biopsy. Following surgical excision of the pannus, representative samples from the AAM surgical sites were stained and evaluated with hematoxylin and eosin for tissue morphology, Masson’s trichrome for collagen, and perilipin for adipocytes. Results:. All subjects tolerated AAM with no severe adverse events reported. At 3 months following implantation, AAM remained visible within the confines of the subjects’ native surrounding adipose tissue with sparse adipocytes apparent within the matrix. By 6 months, AAM had remodeled and was primarily composed of perilipin-positive adipocytes. Histologic analysis confirmed tissue remodeling (hematoxylin and eosin), adipogenesis (perilipin), and angiogenesis (Masson’s trichrome) occurred with the presence of AAM. Conclusions:. AAM is a safe, allogeneic, off-the-shelf regenerative matrix that is adipogenic and noninflammatory and promotes angiogenesis.
url http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000002574
work_keys_str_mv AT laurenekokaiphd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction
AT wesleynsivakmdphd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction
AT benjaminkschillingms clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction
AT arivarasankarunamurthymd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction
AT francescomegrombchbmscmrcs clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction
AT masherschustermanmd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction
AT daniellemminteerphd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction
AT patsysimonrnbs clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction
AT richardadamicomd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction
AT jpeterrubinmd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction
_version_ 1724671746690252800